a significant trendp=0.04
35 There was a significant trend towards greater transfusion risk in patients taking DOACs with increasing CKD stage on presentation (χ 2 p=0.04).
35 There was a significant trend towards greater transfusion risk in patients taking DOACs with increasing CKD stage on presentation (χ 2 p=0.04).